UB
COLL icon

UMB Bank’s Collegium Pharmaceutical COLL Stock Holding History

UMB Bank’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.6K Buy
321
+74
+30% +$3.13K ﹤0.01% 1833
2025
Q4 		$11.4K Buy
247
+89
+56% +$3.72K ﹤0.01% 1775
2025
Q3 		$5.53K Buy
158
+142
+888% +$4.94K ﹤0.01% 1854
2025
Q2 		$473 Sell
16
-130
-89% -$3.71K ﹤0.01% 2074
2025
Q1 		$4.36K Buy
+146
New +$4.46K ﹤0.01% 1798
2024
Q4 		– Sell
-78
Closed -$3.01K – 2094
2024
Q3 		$3.01K Buy
78
+39
+100% +$1.39K ﹤0.01% 1877
2024
Q2 		$1.26K Buy
39
+25
+179% +$867 ﹤0.01% 1914
2024
Q1 		$543 Buy
+14
New +$490 ﹤0.01% 1961

Other funds holding COLL

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $653B AUM 32.41% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return